Ali Shokoohmand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ali Shokoohmand has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Nikita Mayur Patel
William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
2 shared publications - Alicia J. Didsbury
School of Biological Sciences, Faculty of Science, University of Auckland, Auckland, New Zealand
1 shared publication Andrés Caicedo
Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador; Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina, Quito, Ecuador; Universidad San Francisco de Quito USFQ, USFQ Space Front, Quito, Ecuador; Mito-Act Research Consortium, Quito, Ecuador
1 shared publicationAnna Koptina
1 shared publication- Anna Krasnodembskaya
Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, UK
1 shared publication - Arwa Z. Al-Riyami
Department of Hematology Sultan Qaboos University Hospital, University Medical City Muscat Oman
1 shared publication
Latest Publications
- Open Access
- 26 April 2026
- Published by Elsevier in Cytotherapy
- Vol. 28 (11)
From Classroom to Cleanroom: Building a Skilled Cell and Gene Therapy Workforce
- 26 April 2026
- Published by Elsevier in Cytotherapy
- Vol. 28 (11)
Open AccessFrom Classroom to Cleanroom: Building a Skilled Cell and Gene Therapy Workforce
- Open Access
- 20 November 2025
- Published by Elsevier in Cytotherapy
- Vol. 28 (2) , 102007
Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directions
- 20 November 2025
- Published by Elsevier in Cytotherapy
- Vol. 28 (2) , 102007
Open AccessFate and function of exogenously administered mesenchymal stromal cells: current insights and future directions
- Open Access
- 13 November 2025
- Published by AIP Publishing in APL Bioengineering
- Vol. 9 (4) , 040901
Heparan sulfate as a central modulator of growth factor dynamics in tissue regeneration
Growth factors (GFs) are potent regenerative proteins that modulate biological responses and stimulate tissue repair by activating cell signaling pathways to enhance proliferation, differentiation, and migration. However, the rapid degradation and diffusion characteristics of GFs necessitate the use of supraphysiological doses and/or frequent administrations to maintain therapeutic effects, which can result in reduced efficacy and an increased risk of adverse events. To address these challenges, novel GF delivery systems seek to preserve bioactivity and modulate GF release, ultimately promoting more effective tissue regeneration. Heparan sulfate (HS) is an essential regulator of GF activity, executing molecular recognition and information storage for controlling extracellular matrix remodeling and cellular behavior during tissue development. In this perspective, we summarize the diverse roles of HS in tissue repair, focusing on its interactions with GFs. These include protective functions, the tonic release of GFs, promoting the complexation of GFs with their cognate receptors, and enhancing the activation of intracellular signaling. Finally, we provide perspectives on using HS as a component of novel biomaterials and medical devices for improving tissue regeneration.
- 13 November 2025
- Published by AIP Publishing in APL Bioengineering
- Vol. 9 (4) , 040901
Open AccessHeparan sulfate as a central modulator of growth factor dynamics in tissue regeneration
Growth factors (GFs) are potent regenerative proteins that modulate biological responses and stimulate tissue repair by activating cell signaling pathways to enhance proliferation, differentiation, and migration. However, the rapid degradation and diffusion characteristics of GFs necessitate the use of supraphysiological doses and/or frequent administrations to maintain therapeutic effects, which can result in reduced efficacy and an increased risk of adverse events. To address these challenges, novel GF delivery systems seek to preserve bioactivity and modulate GF release, ultimately promoting more effective tissue regeneration. Heparan sulfate (HS) is an essential regulator of GF activity, executing molecular recognition and information storage for controlling extracellular matrix remodeling and cellular behavior during tissue development. In this perspective, we summarize the diverse roles of HS in tissue repair, focusing on its interactions with GFs. These include protective functions, the tonic release of GFs, promoting the complexation of GFs with their cognate receptors, and enhancing the activation of intracellular signaling. Finally, we provide perspectives on using HS as a component of novel biomaterials and medical devices for improving tissue regeneration.
- Open Access
- 8 January 2021
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 11
Pearl Sac Gene Expression Profiles Associated With Pearl Attributes in the Silver-Lip Pearl Oyster, Pinctada maxima
Pearls are highly prized biomineralized gemstones produced by molluscs. The appearance and mineralogy of cultured pearls can vary markedly, greatly affecting their commercial value. To begin to understand the role of pearl sacs—organs that form in host oysters from explanted mantle tissues that surround and synthesize pearls—we undertook transcriptomic analyses to identify genes that are differentially expressed in sacs producing pearls with different surface and structural characteristics. Our results indicate that gene expression profiles correlate with different pearl defects, suggesting that gene regulation in the pearl sac contributes to pearl appearance and quality. For instance, pearl sacs that produced pearls with surface non-lustrous calcification significantly down-regulate genes associated with cilia and microtubule function compared to pearl sacs giving rise to lustrous pearls. These results suggest that gene expression profiling can advance our understanding of processes that control biomineralization, which may be of direct value to the pearl industry, particularly in relation to defects that result in low value pearls.
- 8 January 2021
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 11
Open AccessPearl Sac Gene Expression Profiles Associated With Pearl Attributes in the Silver-Lip Pearl Oyster, Pinctada maxima
Pearls are highly prized biomineralized gemstones produced by molluscs. The appearance and mineralogy of cultured pearls can vary markedly, greatly affecting their commercial value. To begin to understand the role of pearl sacs—organs that form in host oysters from explanted mantle tissues that surround and synthesize pearls—we undertook transcriptomic analyses to identify genes that are differentially expressed in sacs producing pearls with different surface and structural characteristics. Our results indicate that gene expression profiles correlate with different pearl defects, suggesting that gene regulation in the pearl sac contributes to pearl appearance and quality. For instance, pearl sacs that produced pearls with surface non-lustrous calcification significantly down-regulate genes associated with cilia and microtubule function compared to pearl sacs giving rise to lustrous pearls. These results suggest that gene expression profiling can advance our understanding of processes that control biomineralization, which may be of direct value to the pearl industry, particularly in relation to defects that result in low value pearls.